Treatment of migraine.
D000293:Adolescent; D000328:Adult; D002110:Caffeine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004878:Ergotamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D002110:Caffeine; D004878:Ergotamine